SCHEMBL2927660

SCHEMBL2927660

PCC(C12CC3CC(CC(C3)C1)C2)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A2 O15244 2/20 0.42
SLC47A1 Q96FL8 2/20 0.42
MAPT P10636 1/20 0.41
ALDH1A1 P00352 2/20 0.36
NPC1 O15118 1/20 0.36
EPHX2 P34913 4/20 0.35
GRIN2D O15399 4/20 0.35
GRIN3B O60391 4/20 0.35
GRIN1 Q05586 4/20 0.35
GRIN2A Q12879 4/20 0.35
GRIN2B Q13224 4/20 0.35
GRIN2C Q14957 4/20 0.35
GRIN3A Q8TCU5 4/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
LMNA P02545 2/20 0.33
SLC22A1 O15245 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
STAT6 P42226 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23111395 0.80 SLC22A2 (0.39) SLC22A2SLC47A1MAPTALDH1A1NPC1
SCHEMBL457160 0.77 SLC22A2 (0.37) SLC22A2SLC47A1MAPTALDH1A1NPC1
Iodide SCHEMBL1478375 0.75 SLC22A2 (0.35) SLC22A2SLC47A1MAPTALDH1A1NPC1
SCHEMBL23111401 0.74 SLC22A2 (0.42) SLC22A2SLC47A1MAPTALDH1A1NPC1
SCHEMBL3282755 0.73 EPHX2 (0.36) SLC22A2SLC47A1MAPTALDH1A1NPC1
SCHEMBL3285298 0.73 EPHX2 (0.36) SLC22A2SLC47A1MAPTALDH1A1NPC1
SCHEMBL9282423 0.70 SLC22A2 (0.39) SLC22A2SLC47A1MAPTALDH1A1NPC1
SCHEMBL6346242 0.70 SLC22A2 (0.39) SLC22A2SLC47A1MAPTALDH1A1NPC1
SCHEMBL1092578 0.69 SLC22A2 (0.48) SLC22A2SLC47A1MAPTALDH1A1NPC1
SCHEMBL25492074 0.67 MAPT (0.57) SLC22A2SLC47A1MAPTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12492281-B2 Polyisocyanurate materials as electrical potting compounds COVESTRO DEUTSCHLAND AG (DE) 2025-12-09 US disclosed
EP-3794049-B1 METHOD FOR PRODUCING A POLYISOCYANATE POLYMER AND A POLYISOCYANURATE PLASTIC COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-06-08 EP disclosed
US-11319402-B2 Method for producing a polyisocyanate polymer and a polyisocyanurate plastic COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2022-05-03 US disclosed
US-20220127407-A1 POLYISOCYANURATE MATERIALS AS ELECTRICAL POTTING COMPOUNDS COVESTRO DEUTSCHLAND AG (DE) 2022-04-28 US disclosed
US-11279790-B2 Process for producing polyisocyanurate plastics by means of phosphine catalysis COVESTRO DEUTSCHLAND AG (DE) 2022-03-22 US disclosed
EP-3507321-B1 PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-03-02 EP disclosed
EP-3931185-A1 POLYISOCYANURATE MATERIALS AS ELECTRICAL POTTING COMPOUNDS Covestro Intellectual Property GmbH & Co. KG (DE) 2022-01-05 EP disclosed
US-20210246255-A1 METHOD FOR PRODUCING A POLYISOCYANATE POLYMER AND A POLYISOCYANURATE PLASTIC COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2021-08-12 US disclosed
US-20210214487-A1 METHOD FOR PREPARING COMPOSITE MATERIALS MADE OF POLYETHYLENE FIBERS HAVING AN ULTRA-HIGH MOLECULAR WEIGHT AND CROSS-LINKED POLYISOCYANATES COVESTRO DEUTSCHLAND AG (DE) 2021-07-15 US disclosed
EP-3794050-A1 METHOD FOR PREPARING COMPOSITE MATERIALS MADE OF POLYETHYLENE FIBERS HAVING AN ULTRA-HIGH MOLECULAR WEIGHT AND CROSS-LINKED POLYISOCYANATES Covestro Intellectual Property GmbH & Co. KG (DE) 2021-03-24 EP disclosed
EP-3794049-A1 METHOD FOR PRODUCING A POLYISOCYANATE POLYMER AND A POLYISOCYANURATE PLASTIC Covestro Intellectual Property GmbH & Co. KG (DE) 2021-03-24 EP disclosed
EP-3507321-A1 PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS Covestro Deutschland AG (DE) 2019-07-10 EP disclosed
US-20190202963-A1 PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS COVESTRO DEUTSCHLAND AG (DE) 2019-07-04 US disclosed
WO-2018041800-A1 PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS COVESTRO DEUTSCHLAND AG (DE) 2018-03-08 WO disclosed
US-7709680-B2 Preparation of polyisocyanates containing uretdione groups using phosphine catalysts BAYER MATERIALSCIENCE AG (DE) 2010-05-04 US disclosed
EP-1982979-B1 Manufacture of polyisocyanates containing uretdione groups BAYER MATERIALSCIENCE AG (DE) 2010-01-27 EP disclosed
US-20080262262-A1 Preparation of polyisocyanates containing uretdione groups using phosphine catalysts BAYER MATERIALSCIENCE AG 2008-10-23 US disclosed
EP-1982979-A1 Manufacture of polyisocyanates containing uretdione groups Bayer MaterialScience AG (DE) 2008-10-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080262262-A1 Preparation of polyisocyanates containing uretdione groups using phosphine catalysts PPIP5K2, IPMK, INPP5B SLC22A2 3523/4885SLC47A1 4552/4885MAPT 1959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.